GlaxoSmithKline Intellectual Property Development Ltd
发明人:
BANDYOPADHYAY, Deepak,EIDAM, Patrick M.,GOUGH, Peter J.,HARRIS, Philip Anthony,JEONG, Jae U.,KANG, Jianxing,KING, Bryan Wayne,LAKDAWALA SHAH, Ami,MARQUIS, JR., Robert W.,LEISTER, Lara Kathryn,RAHMAN,
申请号：
HK18108760
公开号：
HK1249100A1
申请日:
2016.02.05
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Disclosed is a compound which is or a tautomer thereof or a salt thereof, pharmaceutical compositions comprising said compound or a tautomer thereof or a pharmaceutically acceptable salt thereof, and the use in the treatment of diseases/disorders which are likely to be regulated at least in part by programmed necrosis, apoptosis or the production of inflammatory cytokines.
